READ-ONLY DIGITIZATION RESULT
A comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): Results from the phase 3 study BRUIN CLL-321.
Br J Haematol · 2026-Mar · PMID 41571607
Panel Time_to_next_treatment质量警告待 EXE 对齐验证
time to next treatment
FIGURE 4 Kaplan–Meier curve of time to next treatment. HR, based on the stratified Cox proportional hazards model, with stratification factors: Deletion 17p presence and receipt of prior venetoclax treatment. Two‐sided p ‐value is based on the stratified log‐rank test for comparing pirtobrutinib versus BendaR. BendaR, bendamustine+rituximab; CI, confidence interval; HR, hazard ratio; NR, not reached.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
| Curve | 序号 | X (norm) | Y (norm) | X (real) | Y (real) | X (pixel) | Y (pixel) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 0.0000 | 0.5040 | 0.0000 | 50.4032 | 48 | 161 |
| 1 | 2 | 0.0016 | 0.5040 | 0.0481 | 50.4032 | 49 | 161 |
| 1 | 3 | 0.2955 | 0.5847 | 8.7500 | 58.4677 | 230 | 141 |
| 1 | 4 | 0.2971 | 0.5323 | 8.7981 | 53.2258 | 231 | 154 |
| 1 | 5 | 0.3036 | 0.5161 | 8.9904 | 51.6129 | 235 | 158 |
| 1 | 6 | 0.3052 | 0.5161 | 9.0385 | 51.6129 | 236 | 158 |
| 1 | 7 | 0.4091 | 0.3911 | 12.1154 | 39.1129 | 300 | 189 |
| 1 | 8 | 0.4107 | 0.3911 | 12.1635 | 39.1129 | 301 | 189 |
| 1 | 9 | 0.4123 | 0.3911 | 12.2115 | 39.1129 | 302 | 189 |
| 1 | 10 | 0.4172 | 0.3911 | 12.3558 | 39.1129 | 305 | 189 |
| 1 | 11 | 0.4188 | 0.3911 | 12.4038 | 39.1129 | 306 | 189 |
| 1 | 12 | 0.4205 | 0.3911 | 12.4519 | 39.1129 | 307 | 189 |
| 1 | 13 | 0.4221 | 0.3911 | 12.5000 | 39.1129 | 308 | 189 |
| 1 | 14 | 0.4237 | 0.3911 | 12.5481 | 39.1129 | 309 | 189 |
| 1 | 15 | 0.4253 | 0.3911 | 12.5962 | 39.1129 | 310 | 189 |
| 1 | 16 | 0.5519 | 0.3911 | 16.3462 | 39.1129 | 388 | 189 |
| 1 | 17 | 0.5536 | 0.3911 | 16.3942 | 39.1129 | 389 | 189 |
| 1 | 18 | 0.5552 | 0.3911 | 16.4423 | 39.1129 | 390 | 189 |
| 1 | 19 | 0.5568 | 0.3911 | 16.4904 | 39.1129 | 391 | 189 |
| 1 | 20 | 0.5584 | 0.3911 | 16.5385 | 39.1129 | 392 | 189 |
| 1 | 21 | 0.5601 | 0.3911 | 16.5865 | 39.1129 | 393 | 189 |
| 1 | 22 | 0.5649 | 0.3911 | 16.7308 | 39.1129 | 396 | 189 |
| 1 | 23 | 0.5666 | 0.3911 | 16.7788 | 39.1129 | 397 | 189 |
| 1 | 24 | 0.5682 | 0.3911 | 16.8269 | 39.1129 | 398 | 189 |
| 1 | 25 | 0.5698 | 0.3911 | 16.8750 | 39.1129 | 399 | 189 |
| 1 | 26 | 0.7419 | 0.2944 | 21.9712 | 29.4355 | 505 | 213 |
| 1 | 27 | 0.7435 | 0.2944 | 22.0192 | 29.4355 | 506 | 213 |
| 1 | 28 | 0.7451 | 0.2944 | 22.0673 | 29.4355 | 507 | 213 |
| 1 | 29 | 0.7468 | 0.2944 | 22.1154 | 29.4355 | 508 | 213 |
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | quality_warning | 待验证 | 1 | 2026-07-23T16:54:48+00:00 |